PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.95%
Revenue growth above 1.5x 3141.T's 2.65%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
3.35%
Gross profit growth similar to 3141.T's 3.16%. Walter Schloss would assume both firms track common industry trends.
-4.69%
Negative EBIT growth while 3141.T is at 21.83%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-15.56%
Negative operating income growth while 3141.T is at 24.06%. Joel Greenblatt would press for urgent turnaround measures.
4.01%
Net income growth under 50% of 3141.T's 17.92%. Michael Burry would suspect the firm is falling well behind a key competitor.
4.00%
EPS growth under 50% of 3141.T's 17.89%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
4.00%
Diluted EPS growth under 50% of 3141.T's 17.89%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.70%
10Y revenue/share CAGR under 50% of 3141.T's 41.87%. Michael Burry would suspect a lasting competitive disadvantage.
2.70%
5Y revenue/share CAGR under 50% of 3141.T's 41.87%. Michael Burry would suspect a significant competitive gap or product weakness.
-21.41%
Negative 3Y CAGR while 3141.T stands at 31.40%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
7.58%
Below 50% of 3141.T's 187.48%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
7.58%
Below 50% of 3141.T's 187.48%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-26.90%
Negative 3Y CAGR while 3141.T is 60.51%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
36.05%
Below 50% of 3141.T's 115.55%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
36.05%
Below 50% of 3141.T's 115.55%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-8.39%
Negative 3Y equity/share growth while 3141.T is at 89.43%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.29%
Negative near-term dividend growth while 3141.T invests at 104.29%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
25112.50%
Our AR growth while 3141.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
1.54%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
10.94%
Positive asset growth while 3141.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.72%
75-90% of 3141.T's 5.49%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
116.68%
Debt growth far above 3141.T's 3.93%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-31.48%
We cut SG&A while 3141.T invests at 0.12%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.